In a similar transgenic AD administration model, FA in combination with octyl gallate (OG) was found effective to improve cognitive behavior, reduction in β-amyloid plaques, enhancing α-secretase activity, increasing cleavage of amyloid β-protein precursor (APP), and inhibiting β-secretase activity. The gene discussed is APP; the disease is Alzheimer disease.